Pardes Biosciences, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
10.33
|
|
Average Rating
|
4.67
|
|
# Strong Buys
|
2
|
|
# Buys
|
1
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2023-03-31
|
-0.37
|
0.00
|
0.37
|
100.00%
|
|
2022-12-31
|
-0.51
|
0.00
|
0.51
|
100.00%
|
|
2022-09-30
|
-0.53
|
-0.40
|
0.13
|
24.53%
|
|
2022-06-30
|
-0.39
|
-0.48
|
-0.09
|
-23.08%
|
|
2022-03-31
|
-0.25
|
-0.38
|
-0.13
|
-52.00%
|
|
2021-12-31
|
-0.22
|
-0.06
|
0.16
|
72.73%
|
|
2021-09-30
|
0.00
|
-0.05
|
0.00
|
0.00%
|
|
2021-06-30
|
0.00
|
-0.08
|
0.00
|
0.00%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-1.26
|
|
2021-12-31
|
-0.20
|
|
2020-12-31
|
0.00
|